New drugs against high blood pressure
Ginagamit ito bilang biologically active na pampadagdag sa pagkain — dagdag na pinagmumulan ng mga bitamina — B2, B6, C, mga organikong asido — mansanas, succinic, glutamine. Mga sangkap: malic acid, succinic acid, glutamic acid, badan extract, ascorbic acid, bitamina B2, B6.
ЧИТАТЬ ДАЛЕЕ ...
New drugs against high blood pressure
Оглавление
Описание New drugs against high blood pressure
Madalas nagtatanong ang mga tao sa mga botika tungkol sa mga gamot laban sa presyon ng bagong henerasyon na walang side effects. Pero sa totoong buhay, hindi ito nangyayari. Lahat ng epektibong gamot ay may kanya-kanyang side effects. Kailangan mong maglaan ng maraming oras kasama ang iyong doktor para piliin ang tamang grupo ng gamot laban sa high blood pressure para sa'yo. Ang mga tableta para pababain ang presyon ng dugo ay natural na nakakatulong para mabilis itong bumalik sa normal, pero inirerekomenda rin na baguhin ang pamumuhay. Ang malusog na pagkain, kontrol sa timbang, regular na ehersisyo, at pag-iwas sa paninigarilyo at alak ay magagandang paraan para maiwasan ang mataas na presyon ng dugo. Siguraduhing mas kaunting sodium (hal. asin) at mas maraming potassium (mga saging, spinach, broccoli) ang mapapasok sa katawan.
New drugs against high blood pressure: progress and prospectsHigh blood pressure, known medically as hypertension, is a worldwide health problem and is considered to be one of the main risk factors for cardiovascular diseases such as heart attack, stroke, and kidney damage. According to estimates by the world health organization (WHO) affects about one billion people worldwide have hypertension. The development of new drugs for the effective reduction of blood pressure is therefore of high clinical and social relevance.Current Therapy ApproachesTraditional treatment strategies include various drug classes:ACE inhibitors (eg, Enalapril), which inhibit the formation of Angiotensin II;AT1‑receptor blockers (e.g., Losartan), which prevent the action of Angiotensin II to its receptors;Beta-blockers (e.g., Metoprolol), the lower the heart rate and force;Calcium channel blockers (e.g. amlodipine), which relax the smooth muscles of the blood vessels;Diuretics (such as hydrochlorothiazide) to reduce the liquid content in the body.In spite of this wide range of options that are resistant hypertension) remains a part of the patient's blood pressure is adequately controlled (or unwanted side effects. This motivates the search for new drugs.Latest DevelopmentsIn the last few years, several innovative approaches have been developed:Endothelin‑receptor antagonists (e.g., Bosentan): they inhibit the effect of the strong Vasoconstrictor Endothelin‑1 and the show, especially in the case of special forms of hypertension (for example, in the case of chronic renal insufficiency), with promising results.Renin inhibitors (such as Aliskiren): By direct inhibition of the enzyme Renin, the whole of the Renin‑Angiotensin‑aldosterone System is broken‑cascade at an early stage. Studies show an effective reduction in blood pressure, however, must be evaluated in long-term data on safety more.Vasopeptidase inhibitors: Combined inhibition of Neprilysin (an enzyme that natriure degrades tables peptides) and ACE. This dual effect leads to greater vasodilation and Natriuresis.Immune therapeutic approaches: Experimental studies of antibodies against Angiotensin II or its receptors to investigate. This could allow a long-lasting blood pressure control.Gene and RNA‑based therapies: approaches to targeted inhibition of the Expression of blood pressure‑regulating proteins (e.g. by means of siRNA against AGTR1) are in preclinical phases.Clinical trials and effectivenessSeveral Phase III trials confirm the efficacy of new substances:In patients with resistant hypertension, the Addition of a Renin‑Inhibitor resulted in a significant reduction in systolic blood pressure by an average of 15.2 mmHg in comparison to the placebo group (p<0,001).Endothelin‑antagonists reduced the mean pulmonary arterial pressure in patients with pulmonary hypertension significantly (to be -10.3 mmHg, 95% CI: -13.1 with to -7.5).Challenges and future prospectsAlthough these new drugs are promising, there are challenges:possible side effects (e.g., Hyperkalemia in Renin inhibitors);high costs in comparison to established therapies;Need for long-term data for the reduction of cardiovascular endpoints.The future of hypertension therapy is located in the personalization: Genetic testing that might allow prediction of individual efficacy and tolerability say. In addition, innovative delivery systems (for example, implants for continuous drug release) to open up new opportunities to improve therapy adherence.ConclusionThe development of new drugs against high blood pressure expands the therapeutic options, and it provides patients with resistant or difficult-to-use yet hypertension, a new hope. Interdisciplinary research and innovative technologies will continue to drive progress in this area.
Зачем нужен New drugs against high blood pressure
Una sa lahat, ang mga Beta-blocker ay karaniwang ibinibigay sa mga pasyente na may heart failure, aortic aneurysm, pagkatapos ng myocardial infarction, at sa mga kababaihan na nasa edad ng pagbubuntis, lalo na sa mga kababaihang nagpaplano ng pagbubuntis. Madalas matanggap ng katawan ang Beta-blocker, pero maaari rin itong magdulot ng pantal sa balat at bradycardia – sobrang bagal ng tibok ng puso. Cardiovascular disease relevance of the topic High blood pressure alcoholCardiovascular disease relevance of the topic
Cardiovascular Disease Examples
Cardiovascular Disease ExamplesМнение эксперта
Ang arteryal na hypertension o hypertension ay isang kondisyon ng patuloy na systolic at diastolic na presyon ng dugo, kung saan ang mga sukatan ay lumalagpas sa 140/90 mmHg. Ang mataas na presyon ay nagpapakita ng mga hindi komportableng sintomas. Отзывы о New drugs against high blood pressure
Алина: My sudden blood pressure diagnosis came at a time when I was too stressed. I was getting frequent headaches but always associated with long hours in front of the screen. Dr. told me to control my blood pressure with medicines, lifestyle changes and diet, or I could get a stroke. My husband bought me Cardio Balance to help me lower down my bp naturally. He was the one who monitored my reading. And to our amazement, it reduced from around 145/115 to 124/82 and stayed there. Honestly, it’s a lifesaver for me.
Как заказать?
Заполните форму для консультации и заказа New drugs against high blood pressure. Оператор уточнит у вас все детали и мы отправим ваш заказ. Через 3-7 дней вы получите посылку и оплатите её при получении.
Cardiovascular Disorders List. Medicines for high blood pressure, older. Face in cardiovascular diseases. Varicose veins is a disease of the cardiovascular System. Ang Cardio Balance Kapseln ay isang epektibo at ligtas na paraan para mapanatili ang kalusugan ng puso at pababain ang presyon ng dugo. Dahil sa kanilang natural na sangkap at mataas na bisa, nagiging maaasahang katuwang sila sa paglaban sa mataas na presyon ng dugo at sa pagpapabuti ng kalidad ng buhay.
Isang malawak na pagpipilian ng mga gamot mismo pati na rin ng mga pamamaraan para sa pagbawas ng gamot mula sa mataas na presyon ang nagbibigay-daan sa iyo na pumili ng pinaka-komportableng programa ng paggamot – ang abot-kaya sa gastos, na may minimal na pagpapakita ng mga side effect, at isinasaalang-alang ang ibang kasamang sakit. Kapag matagal ang pag-inom ng tabletas at binabago ng doktor ang gamot, ito ay dahil ang ilang gamot ay may katangian na magdulot ng pagkagumon, na nagreresulta sa kaunting pagbaba ng bisa nito. Bukod dito, hindi lahat ng grupo ng gamot ay angkop para sa mga pasyente sa iba't ibang edad, at may mga limitasyon din sa pagiging compatible nito sa ibang uri ng gamot.
NSAIDs in cardiovascular diseases
kod-urista.ru/articles/4914-as-for-the-treatment-of-cardiovascular-diseases.html
dem0s.ru/posts/6718-what-is-high-blood-pressure.html
I am happy to offer a scientific Text on the topic of scale for the assessment of the risk of cardiovascular disease in German:Scale for the assessment of the risk of cardiovascular diseases: principles and applicationCardiovascular disease (CVD) is one of the main causes of morbidity and mortality. The early identification of risk factors and the quantitative assessment of individual risk are, therefore, of crucial importance for the prevention and Management of these diseases.1. Definition and objectives of the risk scaleA scale of Risk for cardiovascular disease, is a standardized Instrument developed on the Basis of epidemiological data, and it allows the individual risk of a patient for the Occurrence of cardiovascular events (e.g. myocardial infarction, stroke) within a certain time period (typically 10 years) to estimate.The primary objective of such a scale is:the identification of high-risk individuals;the support of medical decision-making in the therapy of recommendation;the Motivation of patients for the modification of lifestyle factors.2. Known risk scale: SCOREOne of the most widely used instruments in Europe, the SCORE scale (Systematic COronary Risk Evaluation) is. It was developed on the Basis of data from several large prospective studies and take into consideration the following parameters:Age (in years);Gender (male/female);systolic blood pressure (in mmHg);Total cholesterol (in mmol/l or mg/dl);Smoking status (Yes/no).The SCORE scale provides an estimate of the 10‑year risk of a fatal cardiovascular event. The results are divided into three risk categories:low risk (< 1 %);medium risk (1-5 %);high risk (> 5 %).3. For more scales and developmentsIn addition to SCORE more models exist, including:Framingham risk scale (originally developed in the United States, takes into account in addition to HDL‑cholesterol);QRISK3 (used in the UK, integrated additional factors, such as Diabetes, family history);ASCVD risk calculator (by the American Heart Association recommended).4. Limitations and challengesDespite its usefulness, risk scale, have some limitations:they are based on population data and is not able to map the individual risk is always accurate;they do not take into account all relevant factors (e.g., psychosocial Stress, genetic predisposition);regional and ethnic differences can lead to distortions.5. ConclusionScale of risk for cardiovascular diseases are indispensable tools in clinical practice. Their continuous development and validation, taking into account new risk factors and demographic changes are needed to improve prevention policies and to reduce the global burden of cardiovascular diseases.If you want, I can make certain sections in more detail or further aspects!